Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 01/08/2011
PIL Enzira Suspension for injection, pre-filled syringe/Influenza vaccine (split virion, inactivated) PH. Eur.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 17/06/2011 and displayed until 01/08/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
Updated on 10/06/2011 and displayed until 17/06/2011
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 20/08/2010 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change of active ingredient
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 17/08/2009 and displayed until 20/08/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 17/09/2008 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 06/06/2008 and displayed until 17/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/09/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   influenza vaccine